Good evening :)
$
₹
Mednax Inc

Mednax Inc

MD

NYSE
Asset Logo

Mednax Inc

MD

NYSE
$25.931.74% (+0.44)
$
₹
$25.931.74% (+0.44)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Care Facilities

Mid Cap

With a market cap of $2.1B the stock is ranked 2149

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

12.74
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2.46
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$2.05
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0.24
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

8.95%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 8 analysts' reports

Buy
3 analysts
Hold
5 analysts
Sell
0 analyst

Analysts expect a +1.56% price upside over the next year

Current Price$25.93
Target Price$26.33

Company Profile

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Peers

Peers

CVS Health Corp
CVS
CVS Health Corp
P/E Ratio
24.92
24.92
1Y Return
22.28%
22.28%
Buy Reco %
85.71
85.71
Cigna Corp
CI
Cigna Corp
P/E Ratio
11.94
11.94
1Y Return
6.04%
6.04%
Buy Reco %
76.00
76.00
Quest Diagnostics Incorporated
DGX
Quest Diagnostics Incorporated
P/E Ratio
26.25
26.25
1Y Return
35.57%
35.57%
Buy Reco %
50.00
50.00
Laboratory Corporation of America Holdings
LH
Laboratory Corporation of America Holdings
P/E Ratio
26.81
26.81
1Y Return
16.02%
16.02%
Buy Reco %
80.00
80.00
Guardant Health Inc
GH
Guardant Health Inc
P/E Ratio
—
—
1Y Return
211.39%
211.39%
Buy Reco %
95.65
95.65

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Care Facilities

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Mednax Inc 12.742.460.24
CVS Health Corp24.921.510.22
Cigna Corp11.941.790.78

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

492.8
71.7
493.7
33.6
476.1
29.5
487.7
39.8
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue495.10504.29511.15502.36458.35468.84492.87493.77476.19487.78
Net Income4.03-153.0219.4430.4820.7339.2671.7033.6829.5739.84
Net Profit Margin0.81%-30.34%3.80%6.06%4.52%8.37%14.54%6.82%6.21%8.16%
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. Mednax Inc (MD) share price today is $25.93 as of September 19, 2026 at 1:30 AM IST. The stock touched a day high of $25.96 and a day low of $25.29.

  2. Mednax Inc stock trades on NYSE under the ticker symbol MD.

  3. Mednax Inc's market capitalization is $2.12B as of September 19, 2026 at 1:30 AM IST.

  4. Mednax Inc's price-to-earnings (P/E) ratio is 12.74 as of September 18, 2026.

  5. Mednax Inc's price-to-book (P/B) ratio is 2.46 as of September 18, 2026.

  6. Yes, You can buy Mednax Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Mednax Inc shares in three steps: 1. Search Mednax Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Mednax Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Mednax Inc (MD) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.3855 shares at the current price of $25.93.

Loading...